Novo Nordisk A/S (NVO) | Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity
See also
- Johnson & Johnson (JNJ), Common-Size Liabilities and Stockholders' Equity
- Pfizer Inc. (PFE), Common-Size Liabilities and Stockholders' Equity
- Novartis AG (NVS), Common-Size Liabilities and Stockholders' Equity
- Merck & Co. Inc. (MRK), Common-Size Liabilities and Stockholders' Equity
- GlaxoSmithKline PLC (GSK), Common-Size Liabilities and Stockholders' Equity
- Abbott Laboratories (ABT), Common-Size Liabilities and Stockholders' Equity
- Sanofi (SNY), Common-Size Liabilities and Stockholders' Equity
- UnitedHealth Group Inc. (UNH), Common-Size Liabilities and Stockholders' Equity
- Bristol-Myers Squibb Co. (BMY), Common-Size Liabilities and Stockholders' Equity
- AstraZeneca PLC (AZN), Common-Size Liabilities and Stockholders' Equity
- Eli Lilly & Co. (LLY), Common-Size Liabilities and Stockholders' Equity
- Medtronic Inc. (MDT), Common-Size Liabilities and Stockholders' Equity
- Baxter International Inc. (BAX), Common-Size Liabilities and Stockholders' Equity
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Novo Nordisk A/S, Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
 |
Share capital | |
|
|
|
|
|
Treasury shares | |
|
|
|
|
|
Retained earnings | |
|
|
|
|
|
Other reserves | |
|
|
|
|
|
Equity | % |
% |
% |
% |
% |
|
Loans | |
|
|
|
|
|
Deferred income tax liabilities | |
|
|
|
|
|
Retirement benefit obligations | |
|
|
|
|
|
Provisions for product returns | |
|
|
|
|
|
Provision for legal disputes | |
|
|
|
|
|
Other provisions | |
|
|
|
|
|
Provisions | % |
% |
% |
% |
% |
|
Non-current liabilities | % |
% |
% |
% |
% |
|
Current debt | |
|
|
|
|
|
Trade payables | |
|
|
|
|
|
Tax payables | |
|
|
|
|
|
Employee costs payable | |
|
|
|
|
|
Accruals | |
|
|
|
|
|
Taxes and duties payable | |
|
|
|
|
|
R&D clinical trials | |
|
|
|
|
|
Other payables | |
|
|
|
|
|
Other current liabilities | % |
% |
% |
% |
% |
|
Derivative financial instruments | |
|
|
|
|
|
Provisions for sales rebates | |
|
|
|
|
|
Provisions for product returns | |
|
|
|
|
|
Other provisions | |
|
|
|
|
|
Provisions for other liabilities | % |
% |
% |
% |
% |
|
Current liabilities | % |
% |
% |
% |
% |
|
Total liabilities | % |
% |
% |
% |
% |
|
Total equity and liabilities | % |
% |
% |
% |
% |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center